KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 74 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $177 | -93.8% | 98,946 | -88.3% | 0.00% | -92.9% |
| Q4 2022 | $2,873 | -99.9% | 845,744 | -0.6% | 0.01% | -44.0% |
| Q3 2022 | $4,643,000 | +455.4% | 850,576 | +359.0% | 0.02% | +525.0% |
| Q2 2022 | $836,000 | -77.2% | 185,296 | -62.9% | 0.00% | -73.3% |
| Q1 2022 | $3,674,000 | +1003.3% | 498,922 | +776.2% | 0.02% | +1400.0% |
| Q1 2019 | $333,000 | +540.4% | 56,943 | +1293.6% | 0.00% | – |
| Q1 2017 | $52,000 | – | 4,086 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,767,078 | $80,993,000 | 5.22% |
| Palo Alto Investors LP | 4,663,324 | $79,230,000 | 3.17% |
| DOHENY ASSET MANAGEMENT /CA | 282,945 | $4,807,000 | 2.61% |
| Private Capital Advisors, Inc. | 416,900 | $7,083,000 | 2.22% |
| Sandia Holdings, LLC | 119,739 | $2,034,000 | 0.91% |
| Virtus ETF Advisers LLC | 44,986 | $764,000 | 0.68% |
| Birchview Capital, LP | 50,000 | $850,000 | 0.58% |
| Schonfeld Strategic Advisors LLC | 415,600 | $7,061,000 | 0.38% |
| EMERALD ADVISERS, LLC | 561,317 | $9,537,000 | 0.36% |
| Kazazian Asset Management, LLC | 20,672 | $351,000 | 0.32% |